









Markets
/
Stocks
/
nasdaq-lyra
/

Lyra Therapeutics Inc

LYRA

6.790USD

+0.210+3.19%

Market hours （ET）Quotes delayed by 15 min

8.95MMarket Cap

LossP/E TTM



Lyra Therapeutics Inc

6.790

+0.210+3.19%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q3

FY2019Q2

FY2019Q1

Total revenue

-65.60%183.00K

43.15%209.00K

-64.15%195.00K

30.57%598.00K

29.76%532.00K

1227.27%146.00K

51.53%544.00K

-12.76%458.00K

-12.39%410.00K

-95.94%11.00K

2464.29%359.00K

--525.00K

--468.00K

--271.00K

--14.00K

----

Revenue

-65.60%183.00K

43.15%209.00K

-64.15%195.00K

30.57%598.00K

29.76%532.00K

1227.27%146.00K

51.53%544.00K

-12.76%458.00K

-12.39%410.00K

-95.94%11.00K

2464.29%359.00K

--525.00K

--468.00K

--271.00K

--14.00K

----

Operating expenses

-66.17%8.14M

-39.99%9.97M

-43.39%9.83M

19.74%18.40M

35.73%24.06M

20.02%16.62M

14.40%17.37M

2.97%15.37M

43.01%17.72M

-0.42%13.85M

36.86%15.19M

34.88%14.93M

58.26%12.39M

97.21%13.91M

74.37%11.10M

143.45%11.06M

84.35%7.83M

--7.05M

50.57%6.36M

6.17%4.54M

17.22%4.25M

--4.23M

--4.28M

--3.62M

R&D expenses

-73.26%4.88M

-48.13%6.36M

-52.28%5.90M

22.83%13.26M

44.79%18.24M

29.79%12.27M

23.09%12.37M

0.06%10.80M

48.10%12.60M

-8.62%9.45M

41.98%10.05M

43.81%10.79M

78.30%8.51M

176.30%10.34M

90.65%7.08M

256.87%7.50M

60.93%4.77M

--3.74M

30.66%3.71M

-38.44%2.10M

7.24%2.96M

--2.84M

--3.42M

--2.76M

Depreciation, depletion, and amortization

-5.88%128.00K

51.00%151.00K

--39.00K

--145.00K

-52.11%136.00K

-66.67%100.00K

----

-5.33%284.00K

0.00%300.00K

-30.25%279.00K

-0.99%300.00K

328.57%300.00K

631.71%300.00K

1112.12%400.00K

2230.77%303.00K

775.00%70.00K

--41.00K

450.00%33.00K

116.67%13.00K

0.00%8.00K

--6.00K

--8.00K

Operating profit

66.18%-7.96M

40.73%-9.77M

42.72%-9.64M

-19.41%-17.80M

-35.87%-23.52M

-19.06%-16.48M

-13.50%-16.83M

-3.55%-14.91M

-45.18%-17.31M

-1.47%-13.84M

-33.80%-14.83M

-30.14%-14.40M

-52.28%-11.93M

-93.36%-13.64M

-74.15%-11.08M

-143.45%-11.06M

-84.35%-7.83M

---7.05M

-50.57%-6.36M

-6.17%-4.54M

-17.22%-4.25M

---4.23M

---4.28M

---3.62M

Net non-operating interest income (expenses)

Non-operating interest income

-72.56%298.00K

-67.49%435.00K

-51.68%576.00K

-4.68%855.00K

1.31%1.09M

43.41%1.34M

1886.67%1.19M

2538.24%897.00K

7557.14%1.07M

4342.86%933.00K

130.77%60.00K

30.77%34.00K

-51.72%14.00K

-34.38%21.00K

-10.34%26.00K

420.00%26.00K

81.25%29.00K

--32.00K

-53.97%29.00K

-93.75%5.00K

-54.29%16.00K

--63.00K

--80.00K

--35.00K

Special income (expenses)

---885.00K

---1.64M

---2.80M

-1857.85%-31.17M

----

100.00%0.00

--0.00

---1.59M

----

---1.32M

----

Income before tax

61.93%-8.54M

27.52%-10.97M

24.11%-11.87M

-208.34%-48.12M

-38.16%-22.44M

-6.45%-15.14M

-5.89%-15.63M

-8.63%-15.61M

-36.35%-16.24M

-4.44%-14.22M

-33.57%-14.77M

-30.14%-14.37M

-52.67%-11.91M

-93.95%-13.62M

-74.53%-11.05M

-143.15%-11.04M

-84.36%-7.80M

---7.02M

-52.15%-6.33M

-8.07%-4.54M

-17.92%-4.23M

---4.16M

---4.20M

---3.59M

Income tax

-71.43%4.00K

-64.71%6.00K

-56.25%7.00K

0.00%12.00K

0.00%14.00K

30.77%17.00K

--16.00K

--12.00K

--14.00K

--13.00K

----

Income after tax

61.93%-8.55M

27.56%-10.98M

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.25M

-4.54%-14.23M

-33.57%-14.77M

-30.14%-14.37M

-52.67%-11.91M

-93.95%-13.62M

-74.53%-11.05M

-143.15%-11.04M

-84.36%-7.80M

---7.02M

-52.15%-6.33M

-8.07%-4.54M

-17.92%-4.23M

---4.16M

---4.20M

---3.59M

Net income from continuous operations

61.93%-8.55M

27.56%-10.98M

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.25M

-4.54%-14.23M

-33.57%-14.77M

-30.14%-14.37M

-52.67%-11.91M

-93.95%-13.62M

-74.53%-11.05M

-143.15%-11.04M

-84.36%-7.80M

---7.02M

-52.15%-6.33M

-8.07%-4.54M

-17.92%-4.23M

---4.16M

---4.20M

---3.59M

Net income attributable to controlling interests

61.93%-8.55M

27.56%-10.98M

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.25M

-4.54%-14.23M

-33.57%-14.77M

-30.14%-14.37M

-52.67%-11.91M

-93.95%-13.62M

-74.53%-11.05M

-141.55%-11.04M

-80.73%-7.80M

---7.02M

-49.32%-6.33M

-6.80%-4.57M

-17.76%-4.32M

---4.24M

---4.28M

---3.67M

Preferred share dividend

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

-61.54%30.00K

10.39%85.00K

--79.00K

--78.00K

--77.00K

Net income attributable to common shareholders

61.93%-8.55M

27.56%-10.98M

24.14%-11.87M

-208.18%-48.13M

-38.12%-22.45M

-6.47%-15.16M

-5.99%-15.65M

-8.72%-15.62M

-36.47%-16.25M

-4.54%-14.23M

-33.57%-14.77M

-30.14%-14.37M

-52.67%-11.91M

-93.95%-13.62M

-74.53%-11.05M

-141.55%-11.04M

-80.73%-7.80M

---7.02M

-49.32%-6.33M

-6.80%-4.57M

-17.76%-4.32M

---4.24M

---4.28M

---3.67M

Basic earnings per share

62.94%-0.13

31.96%-0.17

33.99%-0.18

-105.63%-0.74

20.52%-0.35

36.15%-0.25

31.46%-0.27

15.51%-0.36

51.80%-0.44

63.16%-0.39

52.84%-0.40

50.19%-0.42

-51.92%-0.92

-93.26%-1.05

-73.50%-0.85

-130.54%-0.85

-73.10%-0.60

---0.54

-43.25%-0.49

-6.80%-0.37

-17.76%-0.35

---0.34

---0.35

---0.30

Diluted earnings per share

62.94%-0.13

31.96%-0.17

33.99%-0.18

-105.63%-0.74

20.52%-0.35

36.15%-0.25

31.46%-0.27

15.51%-0.36

51.80%-0.44

63.16%-0.39

52.84%-0.40

50.19%-0.42

-51.92%-0.92

-93.26%-1.05

-73.50%-0.85

-130.54%-0.85

-73.10%-0.60

---0.54

-43.25%-0.49

-6.80%-0.37

-17.76%-0.35

---0.34

---0.35

---0.30

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

